This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 6, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Save the Date!
Spring Managed Care Forum
May 2-3, 2013
Gaylord Palms
Orlando, Fla.

The NAMCP Behavioral Health Institute (BHI) is pleased to recognize the WVP Health Authority as the 2012 Behavioral Health Innovation Award winner.

Click here for the press release!

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!



Gene patents draw high court review in biotechnology test
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Supreme Court agreed to consider whether human genes can be patented, taking up an issue that has split the medical community and will shape the future of personalized healthcare and the biotechnology industry. More

Childhood cancer-linked mutations may point toward new targets
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The discovery of mutations in two related genes that are involved in neuroblastoma, the most aggressive form of childhood cancer, may identify a novel, defective pathway in these cancers and help uncover potential new therapeutic targets. Neuroblastoma tumors of the peripheral nervous system are the most common solid tumor that occurs in children, accounting for 7 percent of all childhood cancers, but 10 to 15 percent of all childhood cancer-related deaths. More

Earn your MS in Nursing Online

Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

Skin cancer could be genetic
Everyday Health    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Unprotected exposure to the sun isn't the only risk factor for skin cancer. New research suggests your risk level may also depend on your genes and family history. More

 Biotech/Diagnostics/Personalized Medicine

Targeted therapy leads 2012 cancer advances
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Targeted therapies for metastatic HER2-positive breast cancer are among 2012's top advances in oncology, according to a report from the American Society of Clinical Oncology. The recently approved pertuzumab was lauded for slowing disease progression in advanced breast cancer when added to standard therapy, according to researchers. More

Discover the Concentra Difference.

Concentra offers medical practice expertise, operational and peer support, and long-term stability to enable your professional and financial success. Our providers work consistent schedules that encourage healthy work-life balance, and experience the satisfaction of working in an environment designed to reduce administrative burden while allowing more time for patient care.

Partners leading in genetics-based medicine, services
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
With personalized medicine becoming a key focus for medical research and diagnosing conditions, Partners HealthCare System, the Boston region's largest hospital and physicians network, is positioning itself to become a national leader in the emerging field. More

 Regenerative Medicine

Roche, Pfizer, Sanofi plan $72.7 million stem-cell bank
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Drug companies and universities are spending $72.7 million to develop a bank of stem cells to use in testing potential treatments for hard-to- treat diseases. The effort, known as Stembancc and managed by the University of Oxford in England, will focus on generating 1,500 induced pluripotent stem cell lines, researchers said. More

Fast production method increases stem cell yield, safety
Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new method for generating stem cells from mature cells promises to boost stem cell production in the laboratory, helping to remove a barrier to regenerative medicine therapies that would replace damaged or unhealthy body tissues. More

 Emerging Medical Technologies

Is a breath test for colon cancer possible?
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
If colon cancer screening was as easy as taking a breath, more people might do it. Now, a small pilot study suggests such a test could be developed. More

Electronic health records breed digital discontent for some doctors
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two years and $8.4 billion into the government's effort to get doctors to take their practices digital, some unintended consequences are starting to emerge. One is a lot of unhappy doctors. In a big survey by Medscape, 38 percent of the doctors polled said they were unhappy with their electronic medical records system. More

 Managed Healthcare News

UnitedHealth looks at doctors' pay for medical savings
Star Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new report from UnitedHealth Group Inc. takes aim at the way U.S. doctors get paid, saying the nation could save up to $1 trillion over the next decade in healthcare costs if it were possible to "unleash the potential of payment reform initiatives." More

Insurers join former adversaries to publicize health law
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aetna Inc. and other insurers that initially fought President Barack Obama's healthcare overhaul are reversing course and supporting the effort by funding a group planning to spend $100 million to help the uninsured get coverage under the law. More

 FDA: New Treatments and Technology

Study: Extending tamoxifen saves lives, reduces breast cancer recurrences
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a study that many breast cancer experts say may change practice, researchers have reported that extending the use of the drug tamoxifen to 10 years — rather than the currently recommended five years — could save lives by thwarting cancer's return. More

High-dose Zofran pulled from market
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The 32-mg dose of the anti-nausea drug ondansetron has been pulled from the market because of concerns about cardiac problems, the FDA announced. Ondansetron is approved for preventing chemotherapy-induced nausea and vomiting, and, in lower doses, for postoperative nausea and vomiting. The 32-mg formulation is given as a single intravenous dose. More

"Skin cancer is the most common form of cancer in the United States, with more than two million people diagnosed a year, according to the Skin Cancer Foundation."


Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Nov. 29, 2012
Nov. 23, 2012
Nov. 15, 2012
Nov. 8, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063